Table 2.

Characteristics of HSCT patients for posttransplant follow-up study

Characteristics		No cGVHD, n = 19	cGVHD, n = 30
Age at transplant, y	Medium	51	60
	Range	21-69	29-71
Sex, %	F	12 (63)	13 (43)
	M	7 (37)	17 (57)
Disease, %	AML/MDS	12 (63)	24 (80)
	Others	7 (37)	6 (20)
Conditioning regimen, %	MAC	6 (32)	10 (33)
	RIC	13 (68)	20 (67)
Donor type, %	MRD	8 (42)	9 (30)
	MUD	9 (47)	19 (63)
	MMUD	2 (11)	2 (7)
GVHD prophylaxis, %	Tac-MTX	11 (57)	11 (37)
	Tac-Sir	3 (16)	2 (7)
	Tac-Sir-MTX	3 (16)	13 (43)
	Others	4 (21)	4 (13)

Abbreviations are explained in Table 1.